Results showed the combination reduced the risk of death by 24% compared with chemotherapy alone, extending median OS to 18.2 ...

The central finding was the superior activity of a 2-antibody combination against the type 1 mutant CALR neoantigen. Dual ...

Extracellular vesicles play an important role in cell-to-cell communication by transporting proteins and genetic material. Recently, researchers from Japan discovered that vesicles formed from ...

Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational modifications, and aggregation state shape antibody specificity, thereby guiding ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

Partner Therapeutics’ zenocutuzumab-zbco receives US FDA Orphan Drug Designation for treatment of cholangiocarcinoma: Lexington, Massachusetts Saturday, February 7, 2026, 17:00 ...